BEATRICE SAINTARD: Open Payments
NPI 1093339996 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 14 payments from 7 companies in 2025. Trend: 2023 $339 · 2024 $706 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $182 |
| Eisai Inc. | 2 | $60 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $41 |
| Travere Therapeutics, Inc. | 3 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
Products named: JEMPERLI, Lenvima, JOURNAVX, GEMTESA, Cologuard Collection Kit, ELAHERE.
Industry payments across NY — which companies pay providers there.
